KJP Mariaberg
- Address
- Burghaldenstraße 12, 72501 Gammertingen, The Netherlands
KJP Mariaberg - Pediatric Psychopharmacology Research
KJP Mariaberg is a specialized clinical research center focused on advancing the safe and effective use of psychopharmacological interventions in pediatric populations. The center demonstrates particular expertise in optimizing antipsychotic medication management for children and adolescents through innovative therapeutic drug monitoring approaches.
- Therapeutic drug monitoring (TDM) optimization for pediatric antipsychotic medications
- Pharmacokinetic and safety studies of risperidone and aripiprazole in children
- Autism spectrum disorder treatment and medication management
The center's research emphasizes evidence-based strategies to prevent and mitigate medication-related side effects, particularly weight gain associated with antipsychotic use in young patients. Through randomized controlled trials, KJP Mariaberg evaluates the clinical utility of therapeutic drug monitoring as a tool to improve treatment outcomes and enhance medication safety in vulnerable pediatric populations with neurodevelopmental and psychiatric conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in KJP Mariaberg
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Therapeutic Drug Monitoring in Mitigating Risperidone and Aripiprazole-Induced Weight Gain in Pediatric Autism Spectrum Disorder | Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC) | Phase III | Recruiting | Jul 2024 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aripiprazole | 1 | Unknown | 2024-07-16 | 2024-07-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.